Revenue
4.28 million USD
2027 Q1 · USD
Exact inputs and evidence
- Revenue: 4276956 USD Source
Fundies. English
BIOTRICITY INC.
EDGARAnnual consolidated revenue for 2026: about USD 16M, using the latest reported figures. The previous period, 2025, was about USD 13.79M.
Latest quarter
- Cash and cash equivalents
- 467 thousand USD Source
Exact value
466503 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 20.1 million shares Source
Exact value
20074675 shares
Reported share-count change
-24.44% · -6.49 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
16.4 million USD
2025-07-01 – 2026-06-30
Net income
-2.69 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Operating cash flow
162 thousand USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: 42241 USD · 2025-04-01 – 2025-09-30 Source
- Operating cash flow: -373389 USD · 2025-04-01 – 2025-06-30 Source
- Operating cash flow: -698050 USD · 2025-04-01 – 2025-12-31 Source
- Operating cash flow: 42241 USD · 2025-04-01 – 2025-09-30 Source
- Operating cash flow: -718955 USD · 2025-04-01 – 2026-03-31 Source
- Operating cash flow: -698050 USD · 2025-04-01 – 2025-12-31 Source
- Operating cash flow: 507227 USD · 2026-04-01 – 2026-06-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-19.
Financial data available through: 2026-03-31.
Coverage by financial measure
- Revenue: 8 of 11 periods available· newest 2026-03-31
- Operating income: 5 of 11 periods available· newest 2026-03-31
- Net income: 11 of 11 periods available· newest 2026-03-31
- Operating cash flow: 11 of 11 periods available· newest 2026-03-31
- Capital expenditure: 1 of 11 periods available· newest 2022-03-31
- Total assets: 8 of 11 periods available· newest 2026-03-31
- Total liabilities: 8 of 11 periods available· newest 2026-03-31
- Current assets: 8 of 11 periods available· newest 2026-03-31
- Current liabilities: 8 of 11 periods available· newest 2026-03-31
- Cash and cash equivalents: 8 of 11 periods available· newest 2026-03-31
- long term debt: No compatible figures in this window
- Shares outstanding: 8 of 11 periods available· newest 2026-03-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+16%Prior period
USD 13.79 million
–
Current period
USD 16 million
–
Exact inputs and evidence
15998239 − 13790294 = 2207945 USD
13790294 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source15998239 USD · 2025-04-01 – 2026-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 6.02 millionPrior period
−USD 8.42 million
–
Current period
−USD 2.4 million
–
Exact inputs and evidence
-2404139 − -8421179 = 6017040 USD
-8421179 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source-2404139 USD · 2025-04-01 – 2026-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.66 millionPrior period
−USD 2.38 million
–
Current period
−USD 718,955
–
Exact inputs and evidence
-718955 − -2380177 = 1661222 USD
-2380177 USD · 2024-04-01 – 2025-03-31
Inspect prior input Prior source-718955 USD · 2025-04-01 – 2026-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2026 2025-04-01 – 2026-03-31
- Revenue USD 16 million 100% of revenue
- Cost of revenue USD 3.05 million 19% of revenue
- Operating expenses USD 11.26 million 70% of revenue
- Operating income USD 1.69 million 11% of revenue
- Tax, interest and other Derived USD 4.1 million 26% of revenue
- Net income −USD 2.4 million −15% of revenue
Cash
- Operating cash flow −USD 718,955 −4.5% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2019 Not shown: operating income or net income is not reported.
- 2020 Not shown: operating income or net income is not reported.
- 2021 Not shown: operating income or net income is not reported.
- 2022 Operating loss: operating costs were 319% of revenue.
- 2023 Operating loss: operating costs were 260% of revenue.
- 2024 Operating loss: operating costs were 173% of revenue.
- 2025 Operating loss: operating costs were 118% of revenue.
- 2026 Net loss: net income was −15% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2019 2018-04-01 – 2019-03-31 | 398200 | Unavailable | Unavailable | Unavailable | -8592065 | Unavailable | Source
|
| 2020 2019-04-01 – 2020-03-31 | 1417725 | Unavailable | Unavailable | Unavailable | -11066942 | Unavailable | Source
|
| 2021 2020-04-01 – 2021-03-31 | 3384767 | Unavailable | Unavailable | Unavailable | -15491176 | Unavailable | Source
|
| 2022 2021-04-01 – 2022-03-31 | 7650269 | 24387072 Derived | -16736803 | 12393674 Derived | -29130477 | -15193151 Derived | Source
|
| 2023 2022-04-01 – 2023-03-31 | 9639057 | 25048768 Derived | -15409711 | 3248432 Derived | -18658143 | Unavailable | Source
|
| 2024 2023-04-01 – 2024-03-31 | 12063345 | 20891614 Derived | -8828269 | 5266014 Derived | -14094283 | Unavailable | Source
|
| 2025 2024-04-01 – 2025-03-31 | 13790294 | 16239260 Derived | -2448966 | 5972213 Derived | -8421179 | Unavailable | Source
|
| 2026 2025-04-01 – 2026-03-31 | 15998239 | 14307003 Derived | 1691236 | 4095375 Derived | -2404139 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 16M 2026
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Revenue | 398200 |
|
| 2020 | Revenue | 1417725 |
|
| 2021 | Revenue | 3384767 |
|
| 2022 | Revenue | 7650269 |
|
| 2023 | Revenue | 9639057 |
|
| 2024 | Revenue | 12063345 |
|
| 2025 | Revenue | 13790294 |
|
| 2026 | Revenue | 15998239 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
16% 2026
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Year over year | No prior comparable period |
|
| 2020 | Year over year | 256% |
|
| 2021 | Year over year | 138.7% |
|
| 2022 | Year over year | 126% |
|
| 2023 | Year over year | 26% |
|
| 2024 | Year over year | 25.2% |
|
| 2025 | Year over year | 14.3% |
|
| 2026 | Year over year | 16% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin 10.6% 2026
Net margin -15% 2026
Free cash flow margin -198.6% 2022
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019-03-31 | Operating margin | Not reported |
|
| 2020-03-31 | Operating margin | Not reported |
|
| 2021-03-31 | Operating margin | Not reported |
|
| 2022 | Operating margin | -218.8% |
|
| 2023 | Operating margin | -159.9% |
|
| 2024 | Operating margin | -73.2% |
|
| 2025 | Operating margin | -17.8% |
|
| 2026 | Operating margin | 10.6% |
|
| 2019 | Net margin | -2,157.7% |
|
| 2020 | Net margin | -780.6% |
|
| 2021 | Net margin | -457.7% |
|
| 2022 | Net margin | -380.8% |
|
| 2023 | Net margin | -193.6% |
|
| 2024 | Net margin | -116.8% |
|
| 2025 | Net margin | -61.1% |
|
| 2026 | Net margin | -15% |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | -198.6% |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
| 2026 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -719K 2026
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Operating cash flow | -5220847 |
|
| 2020 | Operating cash flow | -7862779 |
|
| 2021 | Operating cash flow | -11080831 |
|
| 2022 | Operating cash flow | -15163384 |
|
| 2023 | Operating cash flow | -13547935 |
|
| 2024 | Operating cash flow | -6693912 |
|
| 2025 | Operating cash flow | -2380177 |
|
| 2026 | Operating cash flow | -718955 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD -15.2M 2022
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | -15193151 |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
| 2026 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
611.3% 2026
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Liabilities / assets | 462.3% |
|
| 2020 | Liabilities / assets | 249.7% |
|
| 2021 | Liabilities / assets | 254% |
|
| 2022 | Liabilities / assets | 112.9% |
|
| 2023 | Liabilities / assets | 404.8% |
|
| 2024 | Liabilities / assets | 604.4% |
|
| 2025 | Liabilities / assets | 632.1% |
|
| 2026 | Liabilities / assets | 611.3% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
0.16× 2026
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Current assets / current liabilities | 0.2× |
|
| 2020 | Current assets / current liabilities | 0.44× |
|
| 2021 | Current assets / current liabilities | 0.41× |
|
| 2022 | Current assets / current liabilities | 3.15× |
|
| 2023 | Current assets / current liabilities | 0.42× |
|
| 2024 | Current assets / current liabilities | 0.2× |
|
| 2025 | Current assets / current liabilities | 0.22× |
|
| 2026 | Current assets / current liabilities | 0.16× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2017 2016-04-01 – 2017-03-31 | −USD 7.81 million Exact valueExact value: -7809291 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.75 million Exact valueExact value: -3748865 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2017-04-01 – 2018-03-31 | −USD 8.62 million Exact valueExact value: -8623738 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.87 million Exact valueExact value: -4874535 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2018-04-01 – 2019-03-31 | −USD 8.59 million Exact valueExact value: -8592065 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.22 million Exact valueExact value: -5220847 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2019-04-01 – 2020-03-31 | −USD 11.07 million Exact valueExact value: -11066942 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.86 million Exact valueExact value: -7862779 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-04-01 – 2021-03-31 | −USD 15.49 million Exact valueExact value: -15491176 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 11.08 million Exact valueExact value: -11080831 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-04-01 – 2022-03-31 | −USD 29.13 million Exact valueExact value: -29130477 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.16 million Exact valueExact value: -15163384 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 29,767 Exact valueExact value: 29767 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.19 million Calculation and evidence-15163384 − 29767 USD Exact free cash flow: -15193151 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2022-04-01 – 2023-03-31 | −USD 18.66 million Exact valueExact value: -18658143 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 13.55 million Exact valueExact value: -13547935 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2023-04-01 – 2024-03-31 | −USD 14.09 million Exact valueExact value: -14094283 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.69 million Exact valueExact value: -6693912 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-04-01 – 2025-03-31 | −USD 8.42 million Exact valueExact value: -8421179 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.38 million Exact valueExact value: -2380177 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2026 2025-04-01 – 2026-03-31 | −USD 2.4 million Exact valueExact value: -2404139 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 718,955 Exact valueExact value: -718955 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
61 filings · 2,587 latest values · 2,587 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001630113, 1630113, BTCY, META, btcy, edgar:1630113, mtsu
Also known as BIOTRICITY INC., BIOTRICITY INC., METASOLUTIONS, INC.